Not Tagged
Not Tagged
[]
 great results from ischemia-extended interim analysis: lower risk of cv mortality and higher risk of non-cv mortality with an initial invasive strategy over a median follow-up of 5.7 years. no overall mortality benefit yet. #aha2022 
Editor-in-Chief International Journal of Cardiovascular Sciences, MD, FACC, FESC, FASNC, Cardiologist, Nuclear Medicine Physician Professor of Medicine at UFF